Considering this, Park et al. [9] found that PTEN targets RAC-alpha serine/threonine-protein kinase (AKT) to generate p21 expression, which in turn causes halting cell cycle progression at the G2/M-phase in NSCLC. The gene discussed is PTEN; the disease is non-small cell lung carcinoma.